D. E. Shaw & Co., Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$13,896,047
-48.4%
136,423
-48.9%
0.01%
-50.0%
Q2 2023$26,937,117
+128.0%
266,942
+107.9%
0.03%
+133.3%
Q1 2023$11,812,800
-14.4%
128,400
-15.6%
0.01%
-20.0%
Q4 2022$13,793,341
+260.3%
152,043
+201.9%
0.02%
+200.0%
Q3 2022$3,828,000
-81.4%
50,365
-79.3%
0.01%
-79.2%
Q2 2022$20,576,000
-57.4%
243,412
-55.7%
0.02%
-46.7%
Q1 2022$48,253,000
-70.9%
549,889
-71.0%
0.04%
-67.2%
Q4 2021$165,634,000
+6724.6%
1,893,604
+6282.2%
0.14%
+6750.0%
Q3 2021$2,427,000
+149.9%
29,670
+178.8%
0.00%
+100.0%
Q2 2021$971,000
-73.6%
10,641
-72.6%
0.00%
-66.7%
Q4 2020$3,673,000
-44.5%
38,900
-48.9%
0.00%
-50.0%
Q3 2020$6,614,000
+8.0%
76,058
+8.5%
0.01%
-14.3%
Q2 2020$6,124,000
-83.2%
70,115
-84.1%
0.01%
-87.7%
Q1 2020$36,373,000
+339.7%
441,150
+405.0%
0.06%
+533.3%
Q4 2019$8,272,000
+144.7%
87,365
+124.6%
0.01%
+125.0%
Q3 2019$3,380,000
-69.5%
38,900
-66.3%
0.00%
-73.3%
Q1 2019$11,083,000
-82.7%
115,282
-84.5%
0.02%
-83.0%
Q4 2018$63,960,000
+277.3%
745,356
+278.9%
0.09%
+340.0%
Q3 2018$16,950,000
-78.7%
196,729
-81.3%
0.02%
-80.8%
Q2 2018$79,520,000
+3576.4%
1,052,685
+3834.8%
0.10%
+3366.7%
Q1 2018$2,163,000
-78.7%
26,753
-77.4%
0.00%
-81.2%
Q3 2017$10,149,000
-28.7%
118,216
-38.3%
0.02%
-36.0%
Q1 2017$14,225,000
-37.0%
191,529
-38.2%
0.02%
-34.2%
Q4 2016$22,589,000
+20.7%
310,124
+30.8%
0.04%
+15.2%
Q3 2016$18,715,000
-18.2%
237,017
-14.5%
0.03%
-21.4%
Q2 2016$22,872,000
-63.3%
277,201
-67.8%
0.04%
-62.5%
Q1 2016$62,375,000
+80.1%
861,055
+114.0%
0.11%
+115.4%
Q4 2015$34,626,000
+7010.1%
402,440
+7493.2%
0.05%
+5100.0%
Q3 2015$487,000
-45.5%
5,300
-41.6%
0.00%0.0%
Q2 2015$893,000
-66.5%
9,079
-66.4%
0.00%
-75.0%
Q1 2015$2,662,000
-91.6%
27,000
-92.1%
0.00%
-90.2%
Q4 2014$31,569,000
-1.6%
340,7000.0%0.04%
-2.4%
Q3 2014$32,070,000
+8.8%
340,700
+4.6%
0.04%
+5.0%
Q2 2014$29,485,000
+8.7%
325,700
+2.1%
0.04%
+2.6%
Q1 2014$27,128,000
-24.7%
319,074
-28.8%
0.04%
-22.0%
Q4 2013$36,005,000
+17.2%
447,934
+11.9%
0.05%
+2.0%
Q3 2013$30,717,000
+16.9%
400,432
+7.7%
0.05%0.0%
Q2 2013$26,286,000371,7450.05%
Other shareholders
NOVARTIS A G shareholders Q4 2014
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders